Followers | 164 |
Posts | 36254 |
Boards Moderated | 2 |
Alias Born | 10/20/2019 |
Thursday, September 29, 2022 7:08:39 AM
*Dr. Dreismann, Former Roche Molecular Diagnostics CEO
*Over 35 years of experience in the life sciences and health care industries
*Mr. Tibbitts, a Highly-accomplished Life-Sciences Executive
*Certified Public Accountant with over 30 years of professional experience as a senior financial executive
*Together provide Extensive Experience in Diagnostics and Financial Strategy
https://finance.yahoo.com/news/mainz-biomed-strengthens-board-directors-110000523.html
Recent MYNZ News
- Mainz Biomed Announces Petra Smeltzer Starke to Join Company as Brand Ambassador • GlobeNewswire Inc. • 09/18/2024 12:01:00 PM
- Mainz Biomed Partners with Liquid Biosciences to Leverage the Power of Artificial Intelligence for the Expansion and Optimization of Biomarker Selection for PancAlert • GlobeNewswire Inc. • 09/04/2024 08:01:00 AM
- Mainz Biomed Launches Enhanced ColoAlert with Cutting-Edge Features to Optimize Screening Efficiency and User Convenience • GlobeNewswire Inc. • 07/25/2024 12:01:00 PM
- Micro Cap Bid Up Following FDA Submission Announcement • AllPennyStocks.com • 07/09/2024 01:30:00 PM
- Mainz Biomed Announces Submission for FDA Breakthrough Device Designation for its Next Generation CRC Screening Test • GlobeNewswire Inc. • 07/09/2024 07:01:00 AM
- Mainz Biomed Provides Half Year 2024 Corporate Update • GlobeNewswire Inc. • 07/02/2024 12:01:00 PM
- Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024 • GlobeNewswire Inc. • 06/03/2024 12:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/31/2024 09:01:03 PM
- Mainz Biomed Reports Results of 2024 Annual General Meeting • GlobeNewswire Inc. • 05/31/2024 09:01:00 PM
- Mainz Biomed to Present New Pooled Colorectal Cancer Screening Data, its Largest Study to Date, at ASCO 2024 Annual Meeting • GlobeNewswire Inc. • 05/28/2024 12:01:00 PM
- Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for its Planned FDA Trial • GlobeNewswire Inc. • 05/20/2024 12:01:00 PM
- Form D/A - Notice of Exempt Offering of Securities: [Amend] • Edgar (US Regulatory) • 05/10/2024 09:20:09 PM
- Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C. • GlobeNewswire Inc. • 05/07/2024 12:01:00 PM
- Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic • GlobeNewswire Inc. • 04/25/2024 01:29:00 PM
- Mainz Biomed Reports Full Year 2023 Financial Results • GlobeNewswire Inc. • 04/09/2024 12:01:00 PM
- Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment • GlobeNewswire Inc. • 03/19/2024 12:01:00 PM
- Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options • GlobeNewswire Inc. • 03/18/2024 12:01:00 PM
- Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations • GlobeNewswire Inc. • 03/12/2024 12:01:00 PM
- Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic • GlobeNewswire Inc. • 03/05/2024 01:01:00 PM
- Mainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical Community • GlobeNewswire Inc. • 02/27/2024 01:01:00 PM
- Mainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert® • GlobeNewswire Inc. • 02/22/2024 01:01:00 PM
- Mainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in Italy • GlobeNewswire Inc. • 02/21/2024 01:01:00 PM
- Mainz Biomed Establishes Physician-Led Laboratory Expanding Service Offering for Privately Insured Patients in Germany • GlobeNewswire Inc. • 02/06/2024 01:01:00 PM
- Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium • GlobeNewswire Inc. • 01/11/2024 01:01:00 PM
- Mainz Biomed Provides Year-End Corporate Review 2023 • GlobeNewswire Inc. • 01/09/2024 01:01:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM